Patents by Inventor Garrett Thomas Potter

Garrett Thomas Potter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
    Patent number: 8314116
    Abstract: Provided herein are 2-S-benzyl pyrimidine compounds having CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity, useful for the prophylaxis and treatment of diseases associated with CRTH2 activity, including the treatment of allergic diseases, eosinophil-related diseases and basophil-related diseases.
    Type: Grant
    Filed: September 24, 2008
    Date of Patent: November 20, 2012
    Assignee: Actimis Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Garrett Thomas Potter, Marie Chantal Siu-Ying Tran
  • ARYLSULFONAMIDE CCR3 ANTAGONISTS
    Publication number: 20110230487
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: March 17, 2011
    Publication date: September 22, 2011
    Inventors: Tai Wei LY, Garrett Thomas Potter, Jared Andrew Forrester
  • ISOTOPICALLY ENRICHED ARYLSULFONAMIDE CCR3 ANTAGONISTS
    Publication number: 20110218207
    Abstract: Provided herein are isotopically enriched arylsulfonamides, for example, of Formula I, that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: March 1, 2011
    Publication date: September 8, 2011
    Applicant: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Garrett Thomas Potter
  • 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS
    Publication number: 20100273785
    Abstract: Provided herein are 2,5-disubstituted arylsulfonamide CCR3 antagonists of Formula I or II, and pharmaceutical compositions thereof: wherein X, Y, Z, and R1-R5 are as defined herein. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: April 21, 2010
    Publication date: October 28, 2010
    Inventors: Tai Wei Ly, Garrett Thomas Potter